NCT00898820View on ClinicalTrials.gov

Tumor Response to Pemetrexed Disodium in Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Enrolled in Clinical Trial MCCRC-RC0524

CompletedOBSERVATIONAL
Enrollment

80

Participants

Timeline

Start Date

November 30, 2006

Primary Completion Date

December 31, 2007

Study Completion Date

December 31, 2007

Conditions
Lung Cancer
Interventions
GENETIC

gene expression analysis

GENETIC

polymorphism analysis

GENETIC

protein expression analysis

Trial Locations (1)

55905

Mayo Clinic, Rochester

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Mayo Clinic

OTHER